epichlorohydrin has been researched along with Colonic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asnani, GP; Kokare, CR | 1 |
| Jeong, YI; Kang, DH; Kim, I; Suh, H; Zhang, L; Zheng, S | 1 |
2 other study(ies) available for epichlorohydrin and Colonic Neoplasms
| Article | Year |
|---|---|
In vitro and in vivo evaluation of colon cancer targeted epichlorohydrin crosslinked Portulaca-alginate beads.
Topics: Administration, Oral; Alginates; Animals; Antineoplastic Agents; Colon; Colonic Neoplasms; Epichlorohydrin; Fluorouracil; HT29 Cells; Humans; Hydrogels; Inhibitory Concentration 50; Microspheres; Plant Mucilage; Portulaca; Rats; Rats, Wistar; Tissue Distribution | 2018 |
Crosslinked poly(ethylene glycol) hydrogels with degradable phosphamide linkers used as a drug carrier in cancer therapy.
Topics: Animals; Antibiotics, Antineoplastic; Carcinoma; Cell Survival; Colonic Neoplasms; Cross-Linking Reagents; Doxorubicin; Drug Carriers; Drug Compounding; Epichlorohydrin; Epoxy Compounds; Female; HEK293 Cells; Humans; Hydrogels; Mice; Mice, Inbred BALB C; Organophosphorus Compounds; Polyethylene Glycols; Xenograft Model Antitumor Assays | 2014 |